The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1648
ISSUE1648
April 18, 2022
A Drug-Eluting Contact Lens for Allergic Conjunctivitis
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
A Drug-Eluting Contact Lens for Allergic Conjunctivitis
April 18, 2022 (Issue: 1648)
The FDA has approved Acuvue Theravision with
Ketotifen (Johnson & Johnson Vision Care), a daily-wear,
disposable, vision-correcting soft contact
lens that releases the H1-antihistamine ketotifen, for
prevention of ocular itch due to allergic...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.